David Miller
Private Equity Investor bei Alpine Bioventures, GP, LLC
Aktive Positionen von David Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01.09.2013 | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Corporate Officer/Principal | 01.04.2023 | - |
Karriereverlauf von David Miller
Ehemalige bekannte Positionen von David Miller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALPINE IMMUNE SCIENCES, INC. | Private Equity Investor | 01.01.2015 | 01.05.2019 |
ANGN BIOM | Corporate Officer/Principal | 01.05.2019 | - |
Biotech Stock Research LLC
Biotech Stock Research LLC Investment ManagersFinance Founded in 1999, Biotech Stock Research LLC, the parent of Biotech Monthly, is a research firm headquartered in Seattle, Washington. The firm conducts primary and secondary research on developmental-stage biotechnology companies. | Analyst-Equity | 01.01.2001 | - |
Vorstandsvorsitzender | 01.01.1999 | - | |
Gründer | 23.11.2010 | - | |
Präsident | 01.01.2001 | - |
Ausbildung von David Miller
Western Washington University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Indien | 2 |
Operativ
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
Analyst-Equity | 1 |
Sektoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALPINE IMMUNE SCIENCES, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Biotech Stock Research LLC
Biotech Stock Research LLC Investment ManagersFinance Founded in 1999, Biotech Stock Research LLC, the parent of Biotech Monthly, is a research firm headquartered in Seattle, Washington. The firm conducts primary and secondary research on developmental-stage biotechnology companies. | Finance |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Finance |
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Health Technology |
- Börse
- Insiders
- David Miller
- Erfahrung